BridgeMD
New treatment option for Renal Colic
Official title Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
ClinicalTrials.gov ID: NCT05776953
What this study is testing
What is Ketorolac?
Ketorolac is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for renal colic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients will be included if they present to the Emergency Department with (all of the following):
- Adult emergency department patients \< 65 years old
- One or more of the following common ED chief complaints associated with the suspected diagnosis of renal colic. These chief complaints include but...
- Pain score of 4 or greater on the 0-10 NRS
- Determination of treatment with IV ketorolac
You likely can't join if
- Patients will be excluded if any of the following apply:
- Allergy to ketorolac
- Pregnant patients
- Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED
- Known or stated history of renal insufficiency
- Body weight \< 50 kg
See the full eligibility criteria
- Patients will be included if they present to the Emergency Department with (all of the following):
- Adult emergency department patients \< 65 years old
- One or more of the following common ED chief complaints associated with the suspected diagnosis of renal colic. These chief complaints include but are not limited to: flank pain, back pain, abdominal pain, left and/or...
- Pain score of 4 or greater on the 0-10 NRS
- Determination of treatment with IV ketorolac
- Patients will be excluded if any of the following apply:
- Allergy to ketorolac
- Pregnant patients
- Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED
- Known or stated history of renal insufficiency
- Body weight \< 50 kg
- Age greater than 65 years
- Patients that do no read/write Spanish or English
The study team makes the final eligibility decision.
Where it's taking place
- Hackensack, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hackensack, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.